Health Care

Why CVS Is Ready to Lose Billions and Stop Selling Cigarettes

The retail juggernaut will stop selling cigarettes and other tobacco products beginning Oct. 1.

Signs outside of a CVS store on November 5, 2013 in San Francisco, California.
National Journal
Add to Briefcase
Sophie Novack and Dustin Volz
Feb. 5, 2014, 3:05 a.m.

CVS Care­mark will cease its sale of ci­gar­ettes and oth­er to­bacco products in all of its CVS/phar­macy stores by Oct. 1, the com­pany an­nounced Wed­nes­day.

The be­hemoth re­tail­er said it will take an an­nu­al hit of $2 bil­lion in rev­en­ue due to its de­cision, a siz­able sum that amounts to just 1.6 per­cent of the com­pany’s $125 bil­lion av­er­age yearly haul.

“End­ing the sale of ci­gar­ettes and to­bacco products at CVS/phar­macy is the right thing for us to do for our cus­tom­ers and our com­pany to help people on their path to bet­ter health,” said Larry J. Merlo, pres­id­ent and CEO of CVS, in a state­ment. “Put simply, the sale of to­bacco products is in­con­sist­ent with our pur­pose.”

But this isn’t just about pub­lic health. Already the de­cision is gar­ner­ing heavy me­dia cov­er­age, which could serve to coun­ter­act the com­pany’s es­tim­ated rev­en­ue short­fall. The move, which some might see as long over­due at a one-stop shop that doubles as a con­veni­ence store and phar­macy, could be a savvy pub­li­city coup that builds brand loy­alty with cer­tain demo­graph­ics. That’s es­pe­cially true of the 67 per­cent of Amer­ic­ans who view smoking as either an ex­tremely or a very ser­i­ous prob­lem for so­ci­ety.

Already Wed­nes­day, Merlo ap­peared on CBS’s This Morn­ing to talk about the de­cision, and his store. “This de­cision really un­der­scores the role that CVS is play­ing in our health care sys­tem,” he told Charlie Rose. “There’s a grow­ing em­phas­is on healthy out­comes, man­aging chron­ic dis­ease.” Merlo also said that the $2 bil­lion an­nu­al loss is part of his com­pany’s long-term growth strategy, and em­phas­ized that “we’re evolving in­to a health care com­pany.”

And it’s per­son­al. Merlo’s fath­er, he told CBS, was a smoker who died young from can­cer. Merlo said he hasn’t yet spoken with oth­er ma­jor drug­store ex­ec­ut­ives about the move.

The White House im­me­di­ately praised the de­cision. Pres­id­ent Obama, who has been a smoker, hailed it as a “power­ful ex­ample” that could help mil­lions of Amer­ic­ans quit smoking.

“Today’s de­cision will help ad­vance my ad­min­is­tra­tion’s ef­forts to re­duce to­bacco-re­lated deaths, can­cer, and heart dis­ease, as well as bring down health care costs—ul­ti­mately sav­ing lives and pro­tect­ing un­told num­bers of fam­il­ies from pain and heart­break for years to come,” Obama said.

The phar­macy will also un­der­take a na­tion­al smoking-ces­sa­tion pro­gram, Merlo said in a state­ment. The pro­gram will be­gin in the spring and in­clude on­line re­sources as well as in­form­a­tion and treat­ment at CVS phar­ma­cies and Minute­Clin­ics.

The an­nounce­ment comes as ef­forts to curb to­bacco use are again in­creas­ing na­tion­wide. The 50th An­nu­al Sur­geon Gen­er­al’s Re­port on Smoking and To­bacco, re­leased last month, ad­ded sev­er­al ail­ments to the roster of dis­eases caused by smoking.

The FDA an­nounced a ma­jor an­ti­to­bacco cam­paign Tues­day to pre­vent and re­duce smoking among young people.

Health and Hu­man Ser­vices Sec­ret­ary Kath­leen Se­beli­us joined the pres­id­ent in ap­plaud­ing the de­cision, call­ing it an “un­pre­ced­en­ted step in the re­tail in­dustry.”

“We need an all-hands-on-deck ef­fort to take to­bacco products out of the hands of Amer­ica’s young gen­er­a­tion, and to help those who are ad­dicted to quit,” she said in a state­ment. “Today’s CVS Care­mark an­nounce­ment helps bring our coun­try closer to achiev­ing a to­bacco-free gen­er­a­tion.”

CVS is the second-largest drug­store chain in the na­tion, be­hind Wal­greens, which also sells to­bacco products. Mi­chael Polzin, a Wal­greens spokes­man, told the Wall Street Journ­al that the com­pany has been “eval­u­at­ing this product cat­egory for some time to bal­ance the choices our cus­tom­ers ex­pect from us, with their on­go­ing health needs.”


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.